KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
Eugen Trinka, Anthony G Marson, Wim Van Paesschen, Reetta Kälviäinen, Jacqueline Marovac, Benjamin Duncan, Sonja Buyle, Yngve Hallström, Petr Hon, Gian Carlo Muscas, Mark Newton, Heinz-Joachim Meencke, Philip E Smith, Bernd Pohlmann-Eden, for the KOMET Study Group
Journal of Neurology, Neurosurgery & Psychiatry Oct 2013, 84 (10) 1138-1147; DOI: 10.1136/jnnp-2011-300376